Article
Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates
30 Oct 2022
Abstract excerpt
Bloodstream infection (BSI) is the most common infectious complication after allogeneic haematopoietic cell transplantation (HCT) affecting 20–60% of patients in the pre- and early post-engraftment phase [ 1 , 2 , 3 ] and later in patients acute graft-versus-host disease (aGvHD) [ 4 ]. While quinolone prophylaxis during aplasia is beneficial to some extent, breakthrough BSIs caused by multidrug-resistant (MDR)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
